■ Are three weeks of oral anticoagulation sufficient for safe cardioversion in atrial fibrillation?

S Naydenov, N Runev, E Manov

Medicina (Kaunas) 2021, vol 57 (6): 554

https://www.mdpi.com/1648-9144/57/6/554

 

■ Large-scale screening studies for atrial fibrillation – is it worth the effort?

  1. Engdahl, M. Rosenqvist

J Intern Med.2021, vol 289(4): 474–49

https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8048511/

 

■ What clinical trials of ablation for atrial fibrillation tell us – and what they do not

Ram Amuthan, Anne B. Curtis

Heart Rhythm O2. 2021, vol 2(2): 174–186

https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8183809/

 

■ Meta-analysis study on direct oral anticoagulants vs warfarin therapy in atrial fibrillation and PCI: Dual or triple approach?

Natale Daniele Brunetti, Lucia Tricarico, Luisa De Gennaro et al

Int J Cardiol Heart Vasc.2020, vol 29: 100569

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330069/

 

■ Is epicardial fat tissue associated with atrial fibrillation recurrence after ablation? A systematic review and meta-analysis

Alireza Sepehri Shamloo, Nikolaos Dagres, Boris Dinov et al

Int J Cardiol Heart Vasc.2019  vol 22: 132–138

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356021/

 

■ Genetics of atrial fibrillation – practical applications for clinical management: if not now, when and how?

Shinwan Kany, Bruno Reissmann, Andreas Metzner et al

Cardiovasc Res.2021, vol 117(7): 1718–1731

https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8208749/

 

■ How will genetics inform the clinical care of atrial fibrillation?

  1. Benjamin Shoemaker, Rajan L. Shah, Dan M. Roden, Marco V. Perez

Circ Res. 2020 Jun 19; 127(1): 111–127

https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8436048/

 

■ Are interactions between epicardial adipose tissue, cardiac fibroblast and cardiac myocytes instrumental in atrial fibrosis and atrial fibrillation?

Anirudh Krishnan, Emily Chilton, Jaishankar Raman et al

Cells.2021, vol 10(9): 2501

https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8467050/

 

■ Racial differences in atrial size and extracellular matrix homeostatic response to hypertension: Is this a potential mechanism of reduced atrial fibrillation in African Americans?

P Badertscher, D Gregg, C F Baicu et al

Heart Rhythm 02 2021, vol 2 (1): 37-45

https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8183868/

 

■ Dr Paulo Fernando Leite

Cardiologia/Prevenção Cardiovascular

Consultório: Rua Padre Rolim 815/sala 601 – Belo Horizonte/MG/Brasil

Tel: 33245518

CRMMG: 7026

Email: pfleite1873@gmail.com

Blog Internet Médica – www.internetmedica.com.br

Data: novembro 2021